Clinical Trial Update: Effect of Rifampin (RIF) on the Pharmacokinetics (PK) of Oral Cabotegravir (CAB) in Healthy Subjects [Phase 1]

View source ↗

Summary

This Phase 1 study investigates the effect of rifampin on the pharmacokinetics of oral cabotegravir in healthy subjects.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• RIFAMPIN (RIFAMPIN)
• cabotegravir (cabotegravir)

Snippet

Sponsor: ViiV Healthcare | Conditions: Infection, Human Immunodeficiency Virus | Phase 1 | Status: COMPLETED